Bank Hapoalim Bm Vbi Vaccines Inc Transaction History

Bank Hapoalim Bm

  • $660 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 08, 2018
SELL
$1.75 - $2.93 $227,498 - $380,897
-129,999 Closed
0 $0
Q2 2018

Jul 24, 2018
BUY
$2.75 - $3.85 $49,843 - $69,781
18,125 Added 16.2%
129,999 $357,000
Q1 2018

Apr 30, 2018
BUY
$3.5 - $4.47 $391,559 - $500,076
111,874 New
111,874 $392,000

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About VBI Vaccines Inc

VBIV Quotes by TradingView
  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Bank Hapoalim Bm Portfolio

Follow Bank Hapoalim Bm and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

News

Stay updated on Bank Hapoalim Bm with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email